TOBREX
3MG/ML OPH GTT SOL 1X5ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 01.04.2022 | |||
Interruption of marketing | 21.03.2022 |
0225174 Lék se stejnými indikacemi v jiné lékové formě |
Manufacturing reasons | 31.03.2022 |
Placing on the market | 21.09.2017 |
All reports are available in the Overview.